{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:58:34Z","timestamp":1790881114194,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Construction of ovarian cancer prognosis model based on cancer stem cells and oxidative stress related genes","award":["20240411"],"award-info":[{"award-number":["20240411"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Some observational studies have suggested an association between pelvic inflammatory disease (PID) and ovarian cancer (OC), but the causality between PID and OC remains unclear. To investigate the causal association between PID and 7 OCs, we performed two-sample bidirectional Mendelian randomization (MR) analyses using genetic variants associated with PID. Pooled data on OC were obtained from the Ovarian Cancer Association Consortium. Effect estimates were obtained by inverse-variance weighting, the weighted median method, MR-Egger regression, and MR pleiotropy residual sum and outlier (MR-PRESSO) tests. The results of the inverse-variance weighting analysis showed that PID incidence risks were not significantly associated with OC, mucinous OC, low malignant potential OC, low-grade serous OC, high-grade serous OC, endometrioid OC, or clear cell OC. In this study, the causalities between PID and 7 OCs were comprehensively assessed, but the identified genetic evidence suggested no possible causalities between PID and 7 OCs in European populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049820","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:01:34Z","timestamp":1784919694000},"page":"e49820","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between pelvic inflammatory disease and ovarian cancer: A bidirectional Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"given":"Kaiyun","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingshuang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Hebei General Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilan","family":"Liu","sequence":"additional","affiliation":[{"name":"Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1674-1603","authenticated-orcid":false,"given":"Zhaoping","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"e1700","DOI":"10.1016\/S2214-109X(23)00406-0","article-title":"Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study.","volume":"11","author":"Frick","year":"2023","journal-title":"Lancet Glob Health"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/clinchem\/hvad202","article-title":"Epidemiology of cancer.","volume":"70","author":"Schwartz","year":"2024","journal-title":"Clin Chem"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-020-00874-6","article-title":"Participation of the ATR\/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer.","volume":"13","author":"Gralewska","year":"2020","journal-title":"J Hematol Oncol"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.semcancer.2022.03.028","article-title":"Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy.","volume":"86","author":"Bose","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jamasurg.2022.5447","article-title":"Assessing breast and ovarian cancer risk prior to gender-affirming surgery.","volume":"158","author":"Cortina","year":"2023","journal-title":"JAMA Surg"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology.","volume":"19","author":"Armstrong","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1200\/JCO.21.01900","article-title":"Modification of the association between frequent aspirin use and ovarian cancer risk: a meta-analysis using individual-level data from two ovarian cancer consortia.","volume":"40","author":"Hurwitz","year":"2022","journal-title":"J Clin Oncol"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1158\/0008-5472.CAN-19-2567","article-title":"A prospective analysis of circulating plasma metabolites associated with ovarian cancer risk.","volume":"80","author":"Zeleznik","year":"2020","journal-title":"Cancer Res"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1470-2045(11)70352-7","article-title":"Pelvic inflammatory disease and ovarian cancer.","volume":"12","author":"van de Laar","year":"2011","journal-title":"Lancet Oncol"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease.","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med"},{"key":"R11-20261001","first-page":"3670","article-title":"Population-based case-control study of ovarian cancer in Shanghai.","volume":"49","author":"Shu","year":"1989","journal-title":"Cancer Res"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jech.46.5.528","article-title":"A case-control study of benign ovarian tumours.","volume":"46","author":"Booth","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.","volume":"122","author":"Merritt","year":"2008","journal-title":"Int J Cancer"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study.","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canep.2018.05.011","article-title":"Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer.","volume":"55","author":"Stewart","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2020.02.002","article-title":"Association between pelvic inflammatory disease and risk of ovarian cancer: an updated meta-analysis.","volume":"157","author":"Piao","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"e1010290","DOI":"10.1371\/journal.pgen.1010290","article-title":"Estimation of causal effects of a time-varying exposure at multiple time points through multivariable Mendelian randomization.","volume":"18","author":"Sanderson","year":"2022","journal-title":"PLoS Genet"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12997\/jla.2019.8.2.67","article-title":"Mendelian randomization analysis in observational epidemiology.","volume":"8","author":"Lee","year":"2019","journal-title":"J Lipid Atheroscler"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ng.3826","article-title":"Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.","volume":"49","author":"Phelan","year":"2017","journal-title":"Nat Genet"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2018.4635","article-title":"Assessment of the relationship between genetic determinants of thyroid function and atrial fibrillation: a Mendelian randomization study.","volume":"4","author":"Ellervik","year":"2019","journal-title":"JAMA Cardiol"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/nu15041057","article-title":"No evidence of a genetic causal relationship between ankylosing spondylitis and gut microbiota: a two-sample Mendelian randomization study.","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13027-017-0134-9","article-title":"The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis.","volume":"12","author":"Ingerslev","year":"2017","journal-title":"Infect Agent Cancer"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1940-6207.CAPR-17-0154","article-title":"Primary immunoprevention of epithelial ovarian carcinoma by vaccination against the extracellular domain of anti-M\u00fcllerian hormone receptor II.","volume":"10","author":"Mazumder","year":"2017","journal-title":"Cancer Prev Res (Phila)"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/JCMA.0000000000000262","article-title":"The recent progress and therapy in endometriosis-associated ovarian cancer.","volume":"83","author":"Su","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology.","volume":"55","author":"Hunn","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer.","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"key":"R36-20261001","first-page":"667","article-title":"Pelvic inflammatory disease and risk of ovarian cancer.","volume":"5","author":"Parazzini","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies.","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am J Epidemiol"},{"key":"R38-20261001","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer.","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R39-20261001","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/IGC.0000000000000235","article-title":"Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study.","volume":"24","author":"McAlpine","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R40-20261001","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2013shifting the paradigm.","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"R41-20261001","first-page":"1459","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.","volume":"24","author":"Rasmussen","year":"2013","journal-title":"Cancer Causes Control"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:00:34Z","timestamp":1790877634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":41,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049820","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"2024-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}